(SALINE)

(SALINE) was reported 4370 times

(SALINE) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYOCARDIAL REPERFUSION INJURY 6 0.1579
1 MYOTONIC DYSTROPHY 5 0.0641
2 GASTROINTESTINAL STOMA OUTPUT DECREASED 5 0.0355
3 NAIL BED INFLAMMATION 8 0.0251
4 TETANY 45 0.0247
5 RAPID CORRECTION OF HYPONATRAEMIA 6 0.0239
6 GASTROINTESTINAL STOMA OUTPUT INCREASED 9 0.0192
7 MENINGITIS CHEMICAL 4 0.0182
8 MATERNAL EXPOSURE DURING DELIVERY 18 0.0182
9 BRACHIAL PLEXOPATHY 4 0.0181
10 PNEUMONITIS ASPIRATION 5 0.0146
11 NASAL MUCOSAL DISORDER 8 0.0137
12 GASTRIC MUCOSA ERYTHEMA 4 0.0121
13 RADIOISOTOPE SCAN ABNORMAL 8 0.0113
14 CAUDA EQUINA SYNDROME 8 0.0104
15 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 11 0.0104
16 STOMA COMPLICATION 10 0.0098
17 STREPTOCOCCAL SEPSIS 10 0.0084
18 OSMOTIC DEMYELINATION SYNDROME 5 0.0068
19 VASCULAR DEVICE INFECTION 30 0.0066
20 PSEUDOMONAL SEPSIS 11 0.0063
21 NEPHROGENIC DIABETES INSIPIDUS 7 0.0061
22 HYPORESPONSIVE TO STIMULI 7 0.0060
23 MARROW HYPERPLASIA 4 0.0059
24 FACIAL DISCOMFORT 4 0.0056
25 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 18 0.0054
26 PARATHYROID TUMOUR BENIGN 4 0.0054
27 EXCESSIVE GRANULATION TISSUE 4 0.0050
28 EXCESSIVE EYE BLINKING 7 0.0047
29 ENDOCRINE OPHTHALMOPATHY 4 0.0046
30 CANDIDA SEPSIS 4 0.0045
31 CARBON DIOXIDE DECREASED 5 0.0043
32 CEREBROSPINAL FLUID LEAKAGE 8 0.0043
33 STAPHYLOCOCCUS TEST POSITIVE 9 0.0043
34 PROCALCITONIN INCREASED 5 0.0043
35 MICROANGIOPATHY 4 0.0043
36 NEUTROPENIC INFECTION 4 0.0042
37 COLON NEOPLASM 4 0.0041
38 BLOOD CHLORIDE INCREASED 7 0.0040
39 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 5 0.0040
40 HYPERNATRAEMIA 20 0.0040
41 ADMINISTRATION SITE EXTRAVASATION 4 0.0040
42 KOUNIS SYNDROME 9 0.0040
43 BRONCHIAL SECRETION RETENTION 5 0.0039
44 VENTRICULAR ARRHYTHMIA 14 0.0038
45 GASTROINTESTINAL STOMA COMPLICATION 6 0.0038
46 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
47 INCORRECT DRUG ADMINISTRATION RATE 16 0.0038
48 ANION GAP INCREASED 5 0.0037
49 GALLBLADDER ENLARGEMENT 4 0.0037
50 AUDITORY DISORDER 5 0.0035
51 INFUSION SITE DISCHARGE 6 0.0034
52 HYPOSMIA 5 0.0033
53 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 18 0.0033
54 SPUTUM INCREASED 7 0.0032
55 JAUNDICE NEONATAL 6 0.0032
56 DRUG CLEARANCE DECREASED 4 0.0031
57 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 8 0.0031
58 BILIRUBIN CONJUGATED INCREASED 7 0.0030
59 ESCHERICHIA BACTERAEMIA 7 0.0030
60 INFUSION SITE EXTRAVASATION 18 0.0029
61 SPINAL CORD INJURY 5 0.0029
62 DEVICE INFUSION ISSUE 7 0.0028
63 PULMONARY FUNCTION TEST DECREASED 12 0.0027
64 INFUSION SITE HAEMORRHAGE 9 0.0027
65 PALLOR 74 0.0027
66 MYASTHENIA GRAVIS CRISIS 4 0.0027
67 BLOOD SODIUM INCREASED 7 0.0026
68 BRAIN DEATH 8 0.0026
69 ADRENOCORTICAL INSUFFICIENCY ACUTE 5 0.0026
70 HYPERAEMIA 5 0.0025
71 SINUS OPERATION 6 0.0025
72 OBSTRUCTION 10 0.0025
73 CAPILLARY LEAK SYNDROME 5 0.0024
74 CATHETER SITE HAEMORRHAGE 6 0.0024
75 PROTEIN TOTAL DECREASED 9 0.0024
76 RHINOVIRUS INFECTION 9 0.0023
77 ACTINIC KERATOSIS 6 0.0023
78 EPIGASTRIC DISCOMFORT 9 0.0023
79 MULTIPLE ALLERGIES 18 0.0023
80 RESPIRATORY ACIDOSIS 9 0.0023
81 AORTIC VALVE STENOSIS 4 0.0022
82 INFUSION SITE PRURITUS 7 0.0022
83 BILE DUCT STONE 7 0.0022
84 BLOOD PRESSURE SYSTOLIC DECREASED 10 0.0022
85 CYSTIC FIBROSIS 12 0.0022
86 VARICOSE VEIN 11 0.0021
87 CONTRAST MEDIA REACTION 5 0.0021
88 PARAESTHESIA ORAL 30 0.0021
89 HYPERVOLAEMIA 10 0.0020
90 ENDOPHTHALMITIS 12 0.0020
91 CRANIOCEREBRAL INJURY 6 0.0020
92 BUNDLE BRANCH BLOCK RIGHT 9 0.0020
93 CHANGE OF BOWEL HABIT 4 0.0019
94 METASTASES TO LYMPH NODES 13 0.0019
95 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 17 0.0019
96 INFUSION SITE SWELLING 12 0.0019
97 PNEUMONIA VIRAL 6 0.0019
98 MYCOBACTERIUM AVIUM COMPLEX INFECTION 5 0.0019
99 NORMAL NEWBORN 10 0.0018
100 DEAFNESS NEUROSENSORY 6 0.0018
101 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 6 0.0018
102 OLIGOHYDRAMNIOS 6 0.0018
103 HYPERCALCAEMIA 22 0.0018
104 FORCED EXPIRATORY VOLUME DECREASED 5 0.0018
105 SKIN NECROSIS 9 0.0017
106 HYPERREFLEXIA 6 0.0017
107 PULMONARY PAIN 5 0.0017
108 HYPOVOLAEMIA 10 0.0017
109 DEPRESSIVE SYMPTOM 6 0.0017
110 HYPOXIA 59 0.0017
111 PULSELESS ELECTRICAL ACTIVITY 7 0.0017
112 ACUTE RESPIRATORY FAILURE 32 0.0017
113 DIABETES INSIPIDUS 4 0.0017
114 HYPERCAPNIA 5 0.0017
115 CANDIDA INFECTION 28 0.0017
116 LYMPHADENITIS 4 0.0017
117 CYTOKINE RELEASE SYNDROME 33 0.0016
118 BLOOD PHOSPHORUS DECREASED 6 0.0016
119 DYSCHEZIA 5 0.0016
120 MASTICATION DISORDER 5 0.0016
121 HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.0016
122 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7 0.0016
123 OLIGURIA 10 0.0016
124 INFREQUENT BOWEL MOVEMENTS 4 0.0016
125 CHRONIC SINUSITIS 6 0.0016
126 PARONYCHIA 7 0.0016
127 OSTEITIS 4 0.0016
128 CANCER PAIN 4 0.0016
129 BLOOD CHLORIDE DECREASED 4 0.0015
130 TACHYPNOEA 21 0.0015
131 COMPARTMENT SYNDROME 4 0.0015
132 CARDIOGENIC SHOCK 22 0.0015
133 HYPERSENSITIVITY VASCULITIS 4 0.0015
134 ARTHRITIS INFECTIVE 7 0.0015
135 APPETITE DISORDER 10 0.0015
136 BLOOD MAGNESIUM DECREASED 13 0.0015
137 BRAIN OEDEMA 19 0.0015
138 AREFLEXIA 4 0.0015
139 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
140 CLONUS 4 0.0015
141 RESPIRATORY TRACT INFECTION 38 0.0015
142 ATELECTASIS 14 0.0014
143 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
144 GRANULOMA 5 0.0014
145 NASAL DRYNESS 9 0.0014
146 ANAL HAEMORRHAGE 4 0.0014
147 DRUG TOLERANCE DECREASED 4 0.0014
148 BRONCHIOLITIS 5 0.0014
149 PRODUCTIVE COUGH 67 0.0014
150 TORSADE DE POINTES 11 0.0014
151 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
152 UNRESPONSIVE TO STIMULI 36 0.0014
153 ERYSIPELAS 7 0.0014
154 PARAPLEGIA 4 0.0014
155 LOW BIRTH WEIGHT BABY 11 0.0014
156 URINE OUTPUT DECREASED 12 0.0014
157 ASTHMATIC CRISIS 5 0.0014
158 FOOD INTOLERANCE 5 0.0014
159 TUMOUR LYSIS SYNDROME 12 0.0014
160 COLD SWEAT 24 0.0014
161 BLOOD CREATINE INCREASED 6 0.0014
162 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 23 0.0014
163 WHEELCHAIR USER 6 0.0013
164 FEELING HOT 82 0.0013
165 CYANOSIS 21 0.0013
166 HYPOAESTHESIA ORAL 20 0.0013
167 PARANASAL SINUS DISCOMFORT 5 0.0013
168 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
169 HYPOTONIA 13 0.0013
170 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
171 NEPHROGENIC ANAEMIA 6 0.0013
172 HYPOALBUMINAEMIA 10 0.0013
173 PSEUDOMONAS INFECTION 11 0.0013
174 FLANK PAIN 12 0.0013
175 ORAL INFECTION 5 0.0013
176 SECRETION DISCHARGE 16 0.0013
177 SEASONAL ALLERGY 18 0.0013
178 WHEEZING 75 0.0013
179 BLOOD ALBUMIN DECREASED 10 0.0013
180 OBSTRUCTIVE AIRWAYS DISORDER 14 0.0013
181 POOR VENOUS ACCESS 13 0.0013
182 BLOOD CALCIUM DECREASED 14 0.0012
183 MYOCARDIAL ISCHAEMIA 14 0.0012
184 DECUBITUS ULCER 10 0.0012
185 POLYURIA 10 0.0012
186 PRODUCT PREPARATION ISSUE 8 0.0012
187 RALES 7 0.0012
188 NEPHRITIS 4 0.0012
189 PREMATURE DELIVERY 19 0.0012
190 UROSEPSIS 11 0.0012
191 BRONCHIECTASIS 8 0.0012
192 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 7 0.0012
193 BOWEL MOVEMENT IRREGULARITY 9 0.0012
194 DRUG TOXICITY 16 0.0012
195 HYPOKALAEMIA 54 0.0012
196 LEUKOCYTOSIS 21 0.0012
197 JOINT EFFUSION 8 0.0012
198 APNOEA 9 0.0012
199 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
200 NO THERAPEUTIC RESPONSE 14 0.0011
201 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
202 WEIGHT FLUCTUATION 12 0.0011
203 EAR PRURITUS 4 0.0011
204 NECROTISING FASCIITIS 4 0.0011
205 JAUNDICE CHOLESTATIC 4 0.0011
206 PHYSICAL DISABILITY 5 0.0011
207 SINUS TACHYCARDIA 16 0.0011
208 NEUTROPENIC SEPSIS 8 0.0011
209 IMPLANT SITE PAIN 5 0.0011
210 MENINGITIS ASEPTIC 5 0.0011
211 SINUS DISORDER 22 0.0011
212 BLOOD BILIRUBIN INCREASED 30 0.0011
213 BONE LESION 4 0.0011
214 ABNORMAL FAECES 9 0.0011
215 HYPOTHERMIA 11 0.0011
216 VENTRICULAR FIBRILLATION 12 0.0011
217 PNEUMOTHORAX 17 0.0011
218 ACUTE PULMONARY OEDEMA 6 0.0011
219 OXYGEN SATURATION DECREASED 60 0.0011
220 YELLOW SKIN 5 0.0011
221 METABOLIC ACIDOSIS 34 0.0011
222 CHOLECYSTITIS ACUTE 6 0.0011
223 PERONEAL NERVE PALSY 6 0.0011
224 RESPIRATORY DISTRESS 29 0.0010
225 COMMUNICATION DISORDER 4 0.0010
226 ATRIOVENTRICULAR BLOCK COMPLETE 7 0.0010
227 ENTEROCOLITIS 6 0.0010
228 SINUS BRADYCARDIA 10 0.0010
229 HYPONATRAEMIA 58 0.0010
230 VENTRICULAR TACHYCARDIA 17 0.0010
231 EJECTION FRACTION DECREASED 16 0.0010
232 CARDIOPULMONARY FAILURE 4 0.0010
233 HEREDITARY ANGIOEDEMA 11 0.0010
234 PERIPHERAL COLDNESS 14 0.0010
235 BRADYCARDIA 54 0.0010
236 C-REACTIVE PROTEIN INCREASED 37 0.0010
237 STAPHYLOCOCCAL SEPSIS 5 0.0010
238 MUCOUS STOOLS 5 0.0010
239 THIRST 18 0.0010
240 RENAL CYST 8 0.0010
241 HYPOAESTHESIA 150 0.0010
242 PNEUMONIA ASPIRATION 25 0.0010
243 ARTERIOSPASM CORONARY 4 0.0010
244 OROPHARYNGEAL DISCOMFORT 9 0.0010
245 KLEBSIELLA INFECTION 5 0.0010
246 FOETAL GROWTH RESTRICTION 6 0.0010
247 MOTOR DYSFUNCTION 10 0.0010
248 NEPHROPATHY TOXIC 11 0.0010
249 NEUTROPHIL COUNT INCREASED 10 0.0010
250 EAR DISCOMFORT 10 0.0010
251 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
252 EXTRAVASATION 4 0.0010
253 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
254 LEG AMPUTATION 4 0.0010
255 PARAESTHESIA 152 0.0010
256 HYPERBILIRUBINAEMIA 10 0.0010
257 PREMATURE BABY 29 0.0010
258 FAILURE TO THRIVE 5 0.0010
259 BLOOD SODIUM DECREASED 18 0.0010
260 PAIN IN JAW 27 0.0010
261 SPINAL DISORDER 9 0.0009
262 SERUM FERRITIN INCREASED 5 0.0009
263 HYPOPHOSPHATAEMIA 7 0.0009
264 INCONTINENCE 10 0.0009
265 ABSCESS LIMB 4 0.0009
266 ANAL ABSCESS 5 0.0009
267 TROPONIN INCREASED 7 0.0009
268 ACIDOSIS 7 0.0009
269 INSURANCE ISSUE 14 0.0009
270 DIVERTICULUM INTESTINAL 4 0.0009
271 ASPIRATION 10 0.0009
272 SPINAL OSTEOARTHRITIS 8 0.0009
273 STAPHYLOCOCCAL INFECTION 30 0.0009
274 CARDIAC ARREST 75 0.0009
275 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
276 RESPIRATORY DISORDER 27 0.0009
277 CHOLECYSTITIS CHRONIC 6 0.0009
278 HAEMOPTYSIS 25 0.0009
279 SMALL INTESTINAL OBSTRUCTION 11 0.0009
280 HAEMARTHROSIS 8 0.0009
281 SNEEZING 20 0.0009
282 POSTOPERATIVE WOUND INFECTION 6 0.0009
283 SINUS CONGESTION 12 0.0009
284 DRY THROAT 9 0.0009
285 SLUGGISHNESS 9 0.0009
286 RESPIRATORY TRACT CONGESTION 14 0.0009
287 LOWER RESPIRATORY TRACT INFECTION 40 0.0009
288 DYSPNOEA EXERTIONAL 33 0.0009
289 HYPERTONIA 5 0.0009
290 ANGINA PECTORIS 25 0.0009
291 MIOSIS 7 0.0009
292 EXERCISE TOLERANCE DECREASED 5 0.0009
293 PETECHIAE 9 0.0009
294 HYPOMAGNESAEMIA 12 0.0009
295 STRESS CARDIOMYOPATHY 5 0.0009
296 HEPATIC ENCEPHALOPATHY 8 0.0009
297 HICCUPS 7 0.0009
298 LYMPHOCYTE COUNT DECREASED 15 0.0008
299 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
300 BLOOD UREA INCREASED 14 0.0008
301 ORAL CANDIDIASIS 11 0.0008
302 HYPOVOLAEMIC SHOCK 4 0.0008
303 PULMONARY CONGESTION 11 0.0008
304 KIDNEY TRANSPLANT REJECTION 4 0.0008
305 FAECAL INCONTINENCE 4 0.0008
306 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
307 MOUTH HAEMORRHAGE 6 0.0008
308 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0008
309 ANURIA 7 0.0008
310 NASAL POLYPS 4 0.0008
311 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
312 PANCREATIC DISORDER 4 0.0008
313 MEDICAL DEVICE COMPLICATION 6 0.0008
314 BREATH SOUNDS ABNORMAL 4 0.0008
315 PYELONEPHRITIS 7 0.0008
316 DYSGEUSIA 60 0.0008
317 UPPER RESPIRATORY TRACT INFECTION 37 0.0008
318 BRAIN INJURY 8 0.0008
319 ANAPHYLACTIC REACTION 44 0.0008
320 MENTAL STATUS CHANGES 22 0.0008
321 MUSCLE SPASMS 145 0.0008
322 RESPIRATORY RATE INCREASED 7 0.0008
323 CHILLS 92 0.0008
324 AMMONIA INCREASED 4 0.0008
325 SINUSITIS 80 0.0008
326 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 4 0.0008
327 MOVEMENT DISORDER 25 0.0008
328 ELECTROCARDIOGRAM QT PROLONGED 28 0.0008
329 INFUSION SITE PAIN 10 0.0008
330 MUSCULOSKELETAL CHEST PAIN 12 0.0008
331 HYPOTENSION 155 0.0008
332 INCOHERENT 5 0.0008
333 PNEUMONIA BACTERIAL 7 0.0008
334 CHEST DISCOMFORT 78 0.0008
335 BLOOD LACTIC ACID INCREASED 4 0.0008
336 PULMONARY OEDEMA 34 0.0008
337 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
338 CARDIAC FAILURE ACUTE 5 0.0007
339 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
340 FOOD POISONING 4 0.0007
341 SENSORY LOSS 6 0.0007
342 HYPERHIDROSIS 96 0.0007
343 RHINITIS 6 0.0007
344 ARTERIOSCLEROSIS 7 0.0007
345 GINGIVITIS 4 0.0007
346 CARDIO-RESPIRATORY ARREST 31 0.0007
347 MUSCLE TIGHTNESS 12 0.0007
348 SPUTUM DISCOLOURED 7 0.0007
349 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
350 ANAPHYLACTIC SHOCK 19 0.0007
351 HEAD DISCOMFORT 13 0.0007
352 ENCEPHALOPATHY 18 0.0007
353 JAW DISORDER 4 0.0007
354 POST PROCEDURAL COMPLICATION 14 0.0007
355 LYMPHOEDEMA 5 0.0007
356 BLOOD PRESSURE DECREASED 48 0.0007
357 COAGULOPATHY 12 0.0007
358 EAR PAIN 14 0.0007
359 MASS 10 0.0007
360 MALNUTRITION 8 0.0007
361 HEPATOMEGALY 7 0.0007
362 EPISTAXIS 53 0.0007
363 LUNG INFECTION 11 0.0007
364 PULMONARY TOXICITY 5 0.0007
365 BASAL CELL CARCINOMA 11 0.0007
366 THERMAL BURN 5 0.0007
367 GENERALISED ERYTHEMA 4 0.0007
368 BRONCHOSPASM 10 0.0007
369 OEDEMA 38 0.0007
370 LIMB INJURY 19 0.0007
371 BLOOD POTASSIUM DECREASED 21 0.0007
372 SKIN HYPERPIGMENTATION 6 0.0007
373 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
374 ARRHYTHMIA 33 0.0007
375 HYPERVENTILATION 4 0.0007
376 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
377 ELECTROLYTE IMBALANCE 8 0.0007
378 EYELID OEDEMA 8 0.0007
379 GASTROENTERITIS 10 0.0007
380 ORAL DISORDER 5 0.0007
381 INFUSION RELATED REACTION 45 0.0007
382 BRADYKINESIA 4 0.0007
383 COVID-19 PNEUMONIA 8 0.0007
384 BLOOD POTASSIUM INCREASED 11 0.0007
385 VENTRICULAR EXTRASYSTOLES 7 0.0007
386 BLOOD CREATININE INCREASED 44 0.0007
387 SEPSIS 75 0.0007
388 TENDERNESS 7 0.0007
389 IMMUNODEFICIENCY 10 0.0007
390 MACULAR DEGENERATION 8 0.0007
391 ANAL INCONTINENCE 6 0.0007
392 SEPTIC SHOCK 29 0.0007
393 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
394 TACHYCARDIA 59 0.0007
395 GANGRENE 4 0.0007
396 FEBRILE NEUTROPENIA 44 0.0007
397 JOINT DISLOCATION 7 0.0007
398 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
399 COUGH 185 0.0007
400 FLUSHING 67 0.0007
401 INGUINAL HERNIA 4 0.0007
402 RESTLESSNESS 24 0.0007
403 RESPIRATORY DEPRESSION 8 0.0007
404 FACE OEDEMA 11 0.0007
405 DEHYDRATION 87 0.0007
406 PROCEDURAL COMPLICATION 5 0.0007
407 LIVER FUNCTION TEST INCREASED 14 0.0007
408 ALANINE AMINOTRANSFERASE INCREASED 40 0.0007
409 THYROID DISORDER 10 0.0006
410 ASCITES 19 0.0006
411 APHONIA 9 0.0006
412 PLEURAL EFFUSION 39 0.0006
413 DYSKINESIA 26 0.0006
414 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
415 SKIN REACTION 9 0.0006
416 EAR INFECTION 17 0.0006
417 ABORTION INDUCED 6 0.0006
418 ASTHMA 72 0.0006
419 MULTI-ORGAN FAILURE 11 0.0006
420 GASTROINTESTINAL PAIN 7 0.0006
421 INFECTION 92 0.0006
422 VIRAL INFECTION 21 0.0006
423 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
424 SEROTONIN SYNDROME 12 0.0006
425 PULMONARY HYPERTENSION 13 0.0006
426 THROAT IRRITATION 28 0.0006
427 FISTULA 7 0.0006
428 HYPERCHOLESTEROLAEMIA 6 0.0006
429 ACUTE KIDNEY INJURY 95 0.0006
430 FRUSTRATION TOLERANCE DECREASED 5 0.0006
431 FLATULENCE 35 0.0006
432 RESPIRATORY FAILURE 45 0.0006
433 HERPES SIMPLEX 4 0.0006
434 DERMATITIS CONTACT 7 0.0006
435 SCAB 7 0.0006
436 PHARYNGEAL SWELLING 6 0.0006
437 KIDNEY INFECTION 12 0.0006
438 DECREASED IMMUNE RESPONSIVENESS 6 0.0006
439 DYSARTHRIA 23 0.0006
440 EATING DISORDER 13 0.0006
441 FLUID RETENTION 31 0.0006
442 GASTROENTERITIS VIRAL 11 0.0006
443 PNEUMONIA 197 0.0006
444 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
445 DYSPNOEA 343 0.0006
446 WRONG TECHNIQUE IN DRUG USAGE PROCESS 22 0.0006
447 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
448 HYPERGLYCAEMIA 22 0.0006
449 MENSTRUAL DISORDER 5 0.0006
450 ACUTE CORONARY SYNDROME 5 0.0006
451 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
452 INFUSION SITE ERYTHEMA 5 0.0006
453 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
454 LETHARGY 34 0.0006
455 CIRCULATORY COLLAPSE 10 0.0006
456 PYREXIA 203 0.0006
457 HEPATIC CIRRHOSIS 11 0.0006
458 VITAMIN D DECREASED 5 0.0006
459 ASPARTATE AMINOTRANSFERASE INCREASED 31 0.0006
460 ECCHYMOSIS 4 0.0006
461 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
462 HYPOCALCAEMIA 11 0.0006
463 MUSCLE STRAIN 5 0.0006
464 LARGE INTESTINE POLYP 4 0.0006
465 URINARY INCONTINENCE 17 0.0006
466 RHINORRHOEA 37 0.0006
467 NEUROTOXICITY 10 0.0006
468 OSTEOARTHRITIS 24 0.0006
469 LUNG INFILTRATION 5 0.0006
470 GENERALISED OEDEMA 7 0.0006
471 HAEMORRHOIDS 11 0.0006
472 JOINT INJURY 12 0.0006
473 NASAL CONGESTION 33 0.0006
474 MATERNAL EXPOSURE DURING PREGNANCY 50 0.0006
475 DECREASED ACTIVITY 6 0.0006
476 FREQUENT BOWEL MOVEMENTS 15 0.0006
477 DISORIENTATION 22 0.0006
478 ATRIAL FIBRILLATION 54 0.0006
479 MUSCLE ATROPHY 7 0.0006
480 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
481 FLUID OVERLOAD 8 0.0005
482 METASTASES TO BONE 9 0.0005
483 EXOSTOSIS 5 0.0005
484 ABDOMINAL PAIN 127 0.0005
485 MYDRIASIS 7 0.0005
486 PRODUCT ADMINISTRATION ERROR 11 0.0005
487 DENTAL CARIES 6 0.0005
488 FEEDING DISORDER 11 0.0005
489 TASTE DISORDER 11 0.0005
490 IRON DEFICIENCY ANAEMIA 5 0.0005
491 FEELING COLD 15 0.0005
492 PULMONARY MASS 8 0.0005
493 HEPATIC STEATOSIS 10 0.0005
494 PULMONARY EMBOLISM 51 0.0005
495 APPENDICITIS 5 0.0005
496 OCULAR DISCOMFORT 6 0.0005
497 CHROMATURIA 12 0.0005
498 STATUS EPILEPTICUS 6 0.0005
499 SCAR 9 0.0005
500 CHOLECYSTECTOMY 6 0.0005
501 BACK PAIN 122 0.0005
502 HAEMODYNAMIC INSTABILITY 4 0.0005
503 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
504 LIPASE INCREASED 4 0.0005
505 MUSCLE TWITCHING 12 0.0005
506 CHEST PAIN 96 0.0005
507 CONCUSSION 4 0.0005
508 APHTHOUS ULCER 4 0.0005
509 POST PROCEDURAL HAEMORRHAGE 6 0.0005
510 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
511 HEART RATE DECREASED 18 0.0005
512 VOMITING 241 0.0005
513 CHOKING 10 0.0005
514 CARDIOVASCULAR DISORDER 13 0.0005
515 SKIN FISSURES 10 0.0005
516 DEPRESSED MOOD 27 0.0005
517 CORONARY ARTERY OCCLUSION 7 0.0005
518 RENAL TUBULAR NECROSIS 5 0.0005
519 ACUTE MYOCARDIAL INFARCTION 15 0.0005
520 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
521 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
522 BACTERAEMIA 6 0.0005
523 PRODUCT PRESCRIBING ISSUE 11 0.0005
524 HAEMATOCRIT DECREASED 10 0.0005
525 URINARY TRACT INFECTION 86 0.0005
526 MYOCLONUS 6 0.0005
527 GINGIVAL PAIN 4 0.0005
528 SCIATICA 8 0.0005
529 ATRIAL FLUTTER 4 0.0005
530 SKIN DISCOLOURATION 23 0.0005
531 DEVICE OCCLUSION 7 0.0005
532 RENAL FAILURE ACUTE 21 0.0005
533 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
534 BONE MARROW FAILURE 10 0.0005
535 EYELID PTOSIS 5 0.0005
536 DYSURIA 18 0.0005
537 PARALYSIS 7 0.0005
538 HYPERSOMNIA 14 0.0005
539 MUSCLE SPASTICITY 6 0.0005
540 CARDIOMEGALY 6 0.0005
541 ANAEMIA 93 0.0005
542 INJECTION SITE EXTRAVASATION 6 0.0005
543 ESCHERICHIA INFECTION 4 0.0005
544 LIMB DISCOMFORT 15 0.0005
545 LOSS OF CONSCIOUSNESS 62 0.0005
546 WEIGHT DECREASED 135 0.0005
547 PRODUCT AVAILABILITY ISSUE 11 0.0005
548 NECK PAIN 27 0.0005
549 BACTERIAL INFECTION 9 0.0005
550 AGEUSIA 12 0.0005
551 FOETAL EXPOSURE DURING PREGNANCY 39 0.0005
552 DYSPHONIA 28 0.0005
553 INFLUENZA 53 0.0005
554 RESPIRATORY ARREST 13 0.0005
555 HYPOPHAGIA 12 0.0005
556 LUNG DISORDER 23 0.0005
557 PROCEDURAL PAIN 13 0.0005
558 BREAST CANCER METASTATIC 5 0.0005
559 NIGHT SWEATS 15 0.0005
560 MUSCULOSKELETAL DISCOMFORT 8 0.0005
561 HIATUS HERNIA 6 0.0005
562 LACTIC ACIDOSIS 15 0.0005
563 DIPLOPIA 12 0.0005
564 FAECES DISCOLOURED 10 0.0005
565 BRONCHITIS 34 0.0005
566 HAEMORRHAGE 48 0.0005
567 BEDRIDDEN 6 0.0005
568 BLOOD CALCIUM INCREASED 4 0.0005
569 THROMBOCYTOPENIA 51 0.0005
570 NASOPHARYNGITIS 84 0.0005
571 LOCALISED INFECTION 11 0.0005
572 TENDONITIS 7 0.0005
573 OEDEMA PERIPHERAL 55 0.0005
574 TRANSAMINASES INCREASED 10 0.0004
575 NERVE INJURY 5 0.0004
576 URINARY RETENTION 15 0.0004
577 RASH MACULO-PAPULAR 10 0.0004
578 GALLBLADDER DISORDER 8 0.0004
579 FULL BLOOD COUNT DECREASED 9 0.0004
580 GASTROINTESTINAL INFECTION 4 0.0004
581 SKIN INFECTION 5 0.0004
582 PRODUCT USE COMPLAINT 7 0.0004
583 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
584 OSTEOMYELITIS 8 0.0004
585 PNEUMONITIS 12 0.0004
586 BONE DISORDER 8 0.0004
587 SENSORY DISTURBANCE 7 0.0004
588 TINNITUS 20 0.0004
589 DECREASED APPETITE 101 0.0004
590 PERITONITIS 9 0.0004
591 PERICARDIAL EFFUSION 10 0.0004
592 HEPATIC FAILURE 13 0.0004
593 NAUSEA 341 0.0004
594 HUNGER 6 0.0004
595 APHASIA 13 0.0004
596 STOMATITIS 26 0.0004
597 HYPERKALAEMIA 15 0.0004
598 SEIZURE 49 0.0004
599 ATAXIA 5 0.0004
600 DIZZINESS 210 0.0004
601 MUCOSAL INFLAMMATION 11 0.0004
602 FUNGAL INFECTION 14 0.0004
603 MUSCLE RIGIDITY 5 0.0004
604 POLYNEUROPATHY 5 0.0004
605 IMPAIRED QUALITY OF LIFE 6 0.0004
606 CELLULITIS 21 0.0004
607 ANOSMIA 6 0.0004
608 HYPERTHYROIDISM 6 0.0004
609 HERNIA 8 0.0004
610 BURSITIS 5 0.0004
611 ADRENAL INSUFFICIENCY 5 0.0004
612 NOCTURIA 5 0.0004
613 PRESYNCOPE 10 0.0004
614 NEURALGIA 10 0.0004
615 PARKINSONISM 4 0.0004
616 DISCOMFORT 25 0.0004
617 ILLNESS 42 0.0004
618 HYPOTHYROIDISM 13 0.0004
619 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
620 GASTROINTESTINAL HAEMORRHAGE 34 0.0004
621 BODY TEMPERATURE DECREASED 4 0.0004
622 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
623 HEPATOTOXICITY 9 0.0004
624 DELIRIUM 14 0.0004
625 PHARYNGITIS 5 0.0004
626 CATARACT 24 0.0004
627 COLON CANCER 6 0.0004
628 HEPATIC FUNCTION ABNORMAL 15 0.0004
629 OROPHARYNGEAL PAIN 37 0.0004
630 PREGNANCY 8 0.0004
631 BLOOD PRESSURE INCREASED 61 0.0004
632 CARDIAC FAILURE 32 0.0004
633 TREMOR 66 0.0004
634 OFF LABEL USE 348 0.0004
635 ASTHENIA 149 0.0004
636 RECTAL HAEMORRHAGE 17 0.0004
637 ANXIETY 112 0.0004
638 WOUND 11 0.0004
639 NEPHROLITHIASIS 18 0.0004
640 BODY TEMPERATURE INCREASED 8 0.0004
641 EYE PAIN 22 0.0004
642 DEVICE RELATED INFECTION 6 0.0004
643 HAEMOGLOBIN DECREASED 40 0.0004
644 RED BLOOD CELL COUNT DECREASED 11 0.0004
645 THERAPY PARTIAL RESPONDER 6 0.0004
646 SWOLLEN TONGUE 12 0.0004
647 END STAGE RENAL DISEASE 7 0.0004
648 BRAIN FOG 6 0.0004
649 ACCIDENTAL OVERDOSE 14 0.0004
650 RENAL IMPAIRMENT 32 0.0004
651 GASTRITIS 10 0.0004
652 LEUKOPENIA 19 0.0004
653 TOOTH INFECTION 5 0.0004
654 VISION BLURRED 52 0.0004
655 ABSCESS 6 0.0004
656 PAIN 231 0.0004
657 RETCHING 8 0.0004
658 BODY HEIGHT DECREASED 4 0.0004
659 QUALITY OF LIFE DECREASED 5 0.0004
660 PHOTOPHOBIA 7 0.0004
661 GENERAL PHYSICAL HEALTH DETERIORATION 43 0.0004
662 INTESTINAL OBSTRUCTION 14 0.0004
663 PERIPHERAL SWELLING 57 0.0004
664 DEEP VEIN THROMBOSIS 24 0.0004
665 BACK DISORDER 6 0.0004
666 BLOOD URINE PRESENT 7 0.0004
667 INFLAMMATION 19 0.0004
668 NEUTROPHIL COUNT DECREASED 15 0.0004
669 LYMPHADENOPATHY 13 0.0004
670 SLEEP APNOEA SYNDROME 7 0.0004
671 MIGRAINE 35 0.0004
672 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
673 OESOPHAGITIS 4 0.0004
674 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
675 LOWER LIMB FRACTURE 7 0.0004
676 ABDOMINAL PAIN UPPER 75 0.0004
677 ABDOMINAL DISTENSION 38 0.0004
678 OSTEONECROSIS OF JAW 9 0.0004
679 SPEECH DISORDER 19 0.0004
680 ERYTHEMA 74 0.0004
681 HYPERTENSIVE CRISIS 4 0.0004
682 PANCYTOPENIA 20 0.0004
683 EYE PRURITUS 12 0.0004
684 INTESTINAL PERFORATION 4 0.0004
685 THERAPY NON-RESPONDER 16 0.0004
686 PANCREATITIS ACUTE 8 0.0004
687 EYE INFECTION 4 0.0004
688 HYPERTENSION 75 0.0004
689 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
690 MALAISE 155 0.0004
691 NERVOUS SYSTEM DISORDER 11 0.0004
692 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25 0.0004
693 HAEMATURIA 12 0.0004
694 MICTURITION URGENCY 4 0.0003
695 HYPOACUSIS 15 0.0003
696 HEAD INJURY 11 0.0003
697 HAEMATOMA 9 0.0003
698 CYSTITIS 11 0.0003
699 MENTAL DISORDER 15 0.0003
700 SEDATION 9 0.0003
701 NEEDLE ISSUE 10 0.0003
702 RASH MACULAR 12 0.0003
703 MUSCULAR WEAKNESS 39 0.0003
704 DYSSTASIA 10 0.0003
705 PRODUCT PREPARATION ERROR 7 0.0003
706 AGITATION 25 0.0003
707 URTICARIA 57 0.0003
708 ABDOMINAL DISCOMFORT 57 0.0003
709 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
710 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
711 NEUTROPENIA 46 0.0003
712 DISEASE PROGRESSION 40 0.0003
713 SKIN HAEMORRHAGE 5 0.0003
714 CHOLELITHIASIS 11 0.0003
715 DYSPEPSIA 33 0.0003
716 ACCIDENT 4 0.0003
717 GOUT 6 0.0003
718 CONFUSIONAL STATE 54 0.0003
719 HYPERSENSITIVITY 62 0.0003
720 PLASMA CELL MYELOMA 13 0.0003
721 MYELOSUPPRESSION 12 0.0003
722 HEART RATE INCREASED 33 0.0003
723 DIABETIC KETOACIDOSIS 8 0.0003
724 THROAT TIGHTNESS 9 0.0003
725 MOUTH ULCERATION 7 0.0003
726 HOSPITALISATION 51 0.0003
727 SWELLING 31 0.0003
728 NO ADVERSE EVENT 60 0.0003
729 ECONOMIC PROBLEM 5 0.0003
730 SKIN LESION 9 0.0003
731 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 59 0.0003
732 DIARRHOEA 211 0.0003
733 DYSPHAGIA 31 0.0003
734 LIVER INJURY 8 0.0003
735 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
736 FALL 108 0.0003
737 CONJUNCTIVITIS 6 0.0003
738 ANKLE FRACTURE 5 0.0003
739 ILEUS 4 0.0003
740 MIDDLE INSOMNIA 6 0.0003
741 BLISTER 18 0.0003
742 TOXICITY TO VARIOUS AGENTS 54 0.0003
743 HEADACHE 199 0.0003
744 ANGIOEDEMA 14 0.0003
745 ABDOMINAL PAIN LOWER 8 0.0003
746 HAEMATEMESIS 8 0.0003
747 COMA 15 0.0003
748 TOOTH DISORDER 7 0.0003
749 POLLAKIURIA 13 0.0003
750 GLAUCOMA 6 0.0003
751 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
752 LIVER FUNCTION TEST ABNORMAL 9 0.0003
753 INJECTION SITE INDURATION 4 0.0003
754 PALPITATIONS 36 0.0003
755 CONSTIPATION 67 0.0003
756 SWELLING FACE 20 0.0003
757 NERVOUSNESS 16 0.0003
758 MOBILITY DECREASED 22 0.0003
759 PRODUCT DOSE OMISSION ISSUE 90 0.0003
760 ECZEMA 16 0.0003
761 SHOCK 7 0.0003
762 WEIGHT INCREASED 68 0.0003
763 IMMUNE SYSTEM DISORDER 4 0.0003
764 CHRONIC KIDNEY DISEASE 23 0.0003
765 GASTROINTESTINAL DISORDER 27 0.0003
766 CONTUSION 29 0.0003
767 UPPER LIMB FRACTURE 6 0.0003
768 ALOPECIA 59 0.0003
769 EYE HAEMORRHAGE 4 0.0003
770 AGGRESSION 15 0.0003
771 FATIGUE 233 0.0003
772 INJURY 21 0.0003
773 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
774 VERTIGO 18 0.0003
775 OCULAR HYPERAEMIA 14 0.0003
776 DRUG ADMINISTRATION ERROR 9 0.0003
777 LIVER DISORDER 13 0.0003
778 GINGIVAL BLEEDING 4 0.0003
779 EMOTIONAL DISORDER 9 0.0003
780 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
781 CONDITION AGGRAVATED 88 0.0003
782 INTERSTITIAL LUNG DISEASE 14 0.0003
783 ORAL DISCOMFORT 4 0.0003
784 DRUG-INDUCED LIVER INJURY 9 0.0003
785 LOCAL SWELLING 5 0.0003
786 CEREBRAL INFARCTION 7 0.0003
787 RENAL FAILURE 38 0.0003
788 CARPAL TUNNEL SYNDROME 4 0.0003
789 COVID-19 50 0.0003
790 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
791 PRODUCT USE ISSUE 53 0.0003
792 EXTRAPYRAMIDAL DISORDER 7 0.0003
793 PLATELET COUNT DECREASED 30 0.0003
794 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
795 CONVULSION 16 0.0003
796 POOR QUALITY SLEEP 6 0.0003
797 SOMNOLENCE 56 0.0003
798 PRURITUS GENERALISED 6 0.0003
799 GAIT DISTURBANCE 53 0.0003
800 HYPOKINESIA 4 0.0003
801 CRYING 10 0.0003
802 RESTLESS LEGS SYNDROME 5 0.0003
803 IMPAIRED HEALING 9 0.0003
804 EXPOSURE DURING PREGNANCY 17 0.0003
805 THROMBOSIS 22 0.0003
806 BONE PAIN 16 0.0003
807 DRUG RESISTANCE 7 0.0003
808 FEELING ABNORMAL 65 0.0003
809 SYNCOPE 27 0.0003
810 THINKING ABNORMAL 5 0.0003
811 PAIN IN EXTREMITY 79 0.0003
812 GLOSSODYNIA 6 0.0003
813 ORAL PAIN 6 0.0003
814 DEAFNESS 7 0.0003
815 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
816 HAEMORRHAGE INTRACRANIAL 4 0.0003
817 JOINT STIFFNESS 7 0.0003
818 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
819 IRRITABILITY 16 0.0003
820 PANCREATITIS 14 0.0003
821 DRUG INTERACTION 42 0.0003
822 CORONARY ARTERY DISEASE 8 0.0003
823 BLOOD COUNT ABNORMAL 4 0.0003
824 COLITIS 10 0.0003
825 FOOT FRACTURE 5 0.0003
826 OSTEOPENIA 4 0.0003
827 ROAD TRAFFIC ACCIDENT 11 0.0003
828 MEMORY IMPAIRMENT 36 0.0003
829 FEAR 7 0.0003
830 PRURITUS 100 0.0003
831 MYALGIA 44 0.0003
832 RASH PRURITIC 14 0.0003
833 BURNING SENSATION 18 0.0003
834 NEUROPATHY PERIPHERAL 24 0.0003
835 OBESITY 4 0.0003
836 RASH ERYTHEMATOUS 12 0.0003
837 HEPATIC ENZYME INCREASED 17 0.0002
838 INSOMNIA 66 0.0002
839 HERPES ZOSTER 14 0.0002
840 EYE DISORDER 8 0.0002
841 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
842 OSTEOPOROSIS 10 0.0002
843 RIB FRACTURE 5 0.0002
844 EYE SWELLING 9 0.0002
845 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
846 CYTOMEGALOVIRUS INFECTION 4 0.0002
847 ARTHRALGIA 100 0.0002
848 SKIN DISORDER 8 0.0002
849 GAIT INABILITY 8 0.0002
850 UNEVALUABLE EVENT 18 0.0002
851 HALLUCINATION, VISUAL 5 0.0002
852 ANGER 8 0.0002
853 CARDIAC FAILURE CONGESTIVE 19 0.0002
854 RENAL DISORDER 11 0.0002
855 BLOOD CHOLESTEROL INCREASED 11 0.0002
856 DRY MOUTH 19 0.0002
857 SKIN ULCER 6 0.0002
858 THERAPEUTIC RESPONSE DECREASED 14 0.0002
859 DEVICE DEFECTIVE 4 0.0002
860 DEVICE DISLOCATION 10 0.0002
861 ORTHOSTATIC HYPOTENSION 4 0.0002
862 MUSCULOSKELETAL STIFFNESS 20 0.0002
863 DEVICE MALFUNCTION 16 0.0002
864 METASTASES TO LIVER 4 0.0002
865 APPLICATION SITE PAIN 5 0.0002
866 SLEEP DISORDER 16 0.0002
867 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
868 EYE IRRITATION 13 0.0002
869 ISCHAEMIC STROKE 4 0.0002
870 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
871 DRUG INEFFECTIVE 294 0.0002
872 EXTRA DOSE ADMINISTERED 9 0.0002
873 DRY EYE 11 0.0002
874 BALANCE DISORDER 19 0.0002
875 HAEMATOCHEZIA 12 0.0002
876 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
877 RHABDOMYOLYSIS 9 0.0002
878 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
879 SUICIDE ATTEMPT 13 0.0002
880 HOT FLUSH 16 0.0002
881 MUSCULOSKELETAL PAIN 11 0.0002
882 VISUAL IMPAIRMENT 26 0.0002
883 TYPE 2 DIABETES MELLITUS 7 0.0002
884 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
885 PRODUCT USE IN UNAPPROVED INDICATION 51 0.0002
886 ORAL HERPES 4 0.0002
887 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
888 ABASIA 5 0.0002
889 DISABILITY 4 0.0002
890 BLOOD PRESSURE ABNORMAL 4 0.0002
891 LACRIMATION INCREASED 6 0.0002
892 SKIN IRRITATION 9 0.0002
893 THERAPY INTERRUPTED 14 0.0002
894 RASH 85 0.0002
895 COGNITIVE DISORDER 9 0.0002
896 JOINT SWELLING 23 0.0002
897 SKIN EXFOLIATION 16 0.0002
898 DEVICE ISSUE 17 0.0002
899 INJECTION SITE REACTION 13 0.0002
900 JAUNDICE 5 0.0002
901 HALLUCINATION 14 0.0002
902 INJECTION SITE ERYTHEMA 23 0.0002
903 DIABETES MELLITUS 14 0.0002
904 MOOD ALTERED 5 0.0002
905 VISUAL ACUITY REDUCED 6 0.0002
906 LIP SWELLING 6 0.0002
907 ARTHROPATHY 10 0.0002
908 INJECTION SITE PRURITUS 12 0.0002
909 HEART RATE IRREGULAR 4 0.0002
910 ABORTION SPONTANEOUS 7 0.0002
911 INJECTION SITE PAIN 53 0.0002
912 CEREBRAL HAEMORRHAGE 6 0.0002
913 OVERDOSE 36 0.0002
914 BLOOD PRESSURE FLUCTUATION 4 0.0002
915 INCORRECT DOSE ADMINISTERED 38 0.0002
916 CEREBROVASCULAR ACCIDENT 28 0.0002
917 HYPOGLYCAEMIA 8 0.0002
918 PANIC ATTACK 6 0.0002
919 EPILEPSY 5 0.0002
920 INJECTION SITE URTICARIA 4 0.0002
921 FEMUR FRACTURE 5 0.0002
922 DEVICE LEAKAGE 7 0.0002
923 BLOOD GLUCOSE INCREASED 30 0.0002
924 INFLUENZA LIKE ILLNESS 13 0.0002
925 COLITIS ULCERATIVE 7 0.0002
926 HEPATITIS 4 0.0002
927 INTENTIONAL OVERDOSE 10 0.0002
928 HIP FRACTURE 5 0.0002
929 EXPOSURE VIA SKIN CONTACT 4 0.0002
930 OSTEONECROSIS 5 0.0002
931 DRY SKIN 20 0.0001
932 CARDIAC DISORDER 14 0.0001
933 MENSTRUATION IRREGULAR 4 0.0001
934 EMOTIONAL DISTRESS 18 0.0001
935 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 30 0.0001
936 TREATMENT NONCOMPLIANCE 8 0.0001
937 TREATMENT FAILURE 12 0.0001
938 DIVERTICULITIS 4 0.0001
939 MEDICATION ERROR 8 0.0001
940 NEOPLASM PROGRESSION 5 0.0001
941 INTENTIONAL DOSE OMISSION 4 0.0001
942 ARTHRITIS 11 0.0001
943 INJECTION SITE BRUISING 11 0.0001
944 DRUG EFFECT INCOMPLETE 5 0.0001
945 SURGERY 8 0.0001
946 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
947 INJECTION SITE RASH 4 0.0001
948 DRUG EFFECT DECREASED 7 0.0001
949 BONE DENSITY DECREASED 4 0.0001
950 ABNORMAL BEHAVIOUR 5 0.0001
951 SKIN BURNING SENSATION 9 0.0001
952 MOOD SWINGS 4 0.0001
953 BLOOD GLUCOSE DECREASED 6 0.0001
954 DEVICE BREAKAGE 5 0.0001
955 DEPRESSION 28 0.0001
956 MYOCARDIAL INFARCTION 21 0.0001
957 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
958 ILL-DEFINED DISORDER 7 0.0001
959 INTENTIONAL PRODUCT MISUSE 10 0.0001
960 DRUG INTOLERANCE 11 0.0001
961 DEATH 94 0.0001
962 INJECTION SITE MASS 4 0.0001
963 DRUG ABUSE 9 0.0001
964 AMNESIA 7 0.0001
965 NEOPLASM MALIGNANT 7 0.0001
966 MULTIPLE SCLEROSIS 5 0.0001
967 INJECTION SITE SWELLING 8 0.0001
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
969 BLINDNESS 4 0.0001
970 THERAPY CESSATION 5 0.0001
971 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
972 UNDERDOSE 7 0.0001
973 PSORIASIS 12 0.0001
974 PRODUCT STORAGE ERROR 8 0.0001
975 ADVERSE DRUG REACTION 8 0.0001
976 INJECTION SITE HAEMORRHAGE 7 0.0001
977 ADVERSE EVENT 8 0.0001
978 DRUG WITHDRAWAL SYNDROME 7 0.0001
979 DRUG DOSE OMISSION 13 0.0001
980 DERMATITIS ATOPIC 4 0.0001
981 PROSTATE CANCER 6 0.0001
982 DISTURBANCE IN ATTENTION 4 0.0001
983 RHEUMATOID ARTHRITIS 8 0.0001
984 PRODUCT QUALITY ISSUE 9 0.0001
985 ACNE 5 0.0001
986 SUICIDAL IDEATION 5 0.0001
987 DRUG DOSE OMISSION BY DEVICE 4 0.0001
988 DRUG DEPENDENCE 7 0.0000
989 BREAST CANCER 4 0.0000